SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000929638-24-000705
Filing Date
2024-02-14
Accepted
2024-02-14 16:46:08
Documents
1
Group Members
DAVID EINHORNDME ADVISORS GP, LLCDME ADVISORS, LPDME CAPITAL MANAGEMENT, LP

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 sch13ga.htm SC 13G/A 79970
  Complete submission text file 0000929638-24-000705.txt   81668
Mailing Address 140 EAST 45TH STREET 24TH FLOOR NEW YORK NY 10017
Business Address 140 EAST 45TH STREET 24TH FLOOR NEW YORK NY 10017 2129731900
GREENLIGHT CAPITAL INC (Filed by) CIK: 0001079114 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Subject) CIK: 0001835022 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93853 | Film No.: 24639650
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)